Using Global Patient Data to Design Smarter Clinical Trials
Large-scale patient databases and AI analytics can accelerate site activation, strengthen recruitment, and improve trial design.
Gen Li, PhD, MBA, president of Phesi, discussed results from the company's analysis on global inequity in breast cancer development in a video interview with Applied Clinical Trials.
- Geographic concentration of breast cancer trial leaders is in the US and China.
- Operational barriers in lower-income countries are due to traditional business models.
- AI and machine learning can help implement a more patient-centric approach.
Identifying local leaders and redistributing trial workloads can improve recruitment by using AI to identify and activate new sites.
Author's summary: Smarter clinical trials through global patient data and AI.